Document is current
Any future updates will be listed below
-
Authors
Flugel, Christian L. http://orcid.org/0000-0002-8212-9996
Majzner, Robbie G.
Krenciute, Giedre http://orcid.org/0000-0003-4335-0644
Dotti, Gianpietro
Riddell, Stanley R.
Wagner, Dimitrios L. http://orcid.org/0000-0002-2189-3579
Abou-el-Enein, Mohamed http://orcid.org/0000-0003-2903-9040
- License Information
-
More Information
Article History
Accepted: 12 October 2022
First Online: 23 November 2022
Competing interests
: R.G.M. has acted as an adviser and/or consultant of Aptorum Group, Arovella Therapeutics, Immunai, Innervate Radiopharmaceuticals, Link Cell Therapies, Lyell Immunopharma, NKarta, Syncopation Life Sciences, and Zai lab and is a co-founder of and holds equity in Syncopation Life Sciences and Link Cell Therapies. G.K. has patent applications in the field of immunotherapy. G.D. has acted as a scientific adviser and/or consultant of Bellicum Pharmaceutical and Catamaran and Tessa Therapeutics and holds patents in the field of CAR T cells. S.R.R. has acted as a scientific adviser of Adaptive Biotechnologies and Juno Therapeutics, is a co-founder of and has intellectual property licensed to Lyell Immunopharma and Juno Therapeutics, and holds shares in and has received research funding from Lyell Immunopharma. C.L.F., D.L.W. and M.A. declare no competing interests.
